Recombinant Canine IL-1 beta/IL-1F2 Protein 3747-CL-025 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Canine IL-1 beta/IL-1F2 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $424.00Supplier Page View Company Product Page
Catalog Number3747-CL-025
SpeciesCanine
Size25 ug
Molecule NameIL-1 beta/IL-1F2
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight18 kDa
NCBI Gene AliasesIL-1
ApplicationsBioactivity
Conjugate/TagUnconjugated
NCBI Full Gene Nameinterleukin 1 beta
Source/Expression SystemE. coli-derived Recombinant Canine IL-1 beta/IL-1F2 Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) MicroRNA-194 regulates parasitic load and IL-1β-dependent nitric oxide production in the peripheral blood mononuclear cells of dogs with leishmaniasisPLoS neglected tropical diseasesJanuary 1, 2024Costa SF, Soares MF, Poleto Bragato J, Dos Santos MO, Rebech GT, de Freitas JH, de Lima VMF.

(2) Fibronectin Fragments and Inflammation During Canine Intervertebral Disc DiseaseFrontiers in Veterinary ScienceNovember 16, 2020Manuel Roland Schmidli, Aleksandra Sadowska, Iva Cvitas, Benjamin Gantenbein, Heidi E. L. Lischer, Simone Forterre, Wolfgang Hitzl, Franck Forterre, Karin Wuertz-KozakSigmaAldrich) or recombinant canine IL-1β, which was used as positive inflammation control (10 ng/ml, 3747-CL-025, R&D Systems, Inc., Minneapolis, MN 55413, USA) for 18h. Untreated NP cells served as a negative control group

(3) Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcomaCancer gene therapySeptember 1, 2019Konduri V, Halpert MM, Baig YC, Coronado R, Rodgers JR, Levitt JM, Cerroni B, Piscoya S, Wilson N, DiBernardi L, et al.

(4) Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine OsteoarthritisFrontiers in PharmacologyMay 31, 2019Cindy B. McReynolds, Sung Hee Hwang, Jun Yang, Debin Wan, Karen Wagner, Christophe Morisseau, Dongyang Li, William K. Schmidt, Bruce D. HammockO’Brien et al. (2000) Cells were treated with recombinant canine IL1β (Novus Biologicals catalog number 3747-CL-025) in CGS-free media for 2 h at 37°C. After 2 h, the IL1β treated media was aspirated and replaced with

(5) A DNA telomerase vaccine for canine cancer immunotherapyOncotargetMay 21, 2019Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, et al.

(6) Effect of interleukin-1β on occludin mRNA expression in the duodenal and colonic mucosa of dogs with inflammatory bowel diseaseJournal of veterinary internal medicineMay 1, 2018Ogawa M, Osada H, Hasegawa A, Ohno H, Yanuma N, Sasaki K, Shimoda M, Shirai J, Kondo H, Ohmori K.

Be the First to Write a Review!

Recombinant Canine IL-1 beta/IL-1F2 Protein from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (6)

Reviews

Recombinant Canine IL-1 beta/IL-1F2 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map